Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

DocGo (DCGO) EBITDA Margin: 2020-2024

Historic EBITDA Margin for DocGo (DCGO) over the last 5 years, with FY2024 value amounting to 3.2%.

  • DocGo's EBITDA Margin fell 442600.0% to 39.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.98%, marking a year-over-year decrease of 186400.0%. This contributed to the annual value of 3.2% for FY2024, which is 19800.0% up from last year.
  • Latest data reveals that DocGo reported EBITDA Margin of 3.2% as of FY2024, which was up 19800.0% from 1.22% recorded in FY2023.
  • Over the past 5 years, DocGo's EBITDA Margin peaked at 8.03% during FY2022, and registered a low of 15.05% during FY2020.
  • In the last 5 years, DocGo's EBITDA Margin had a median value of 3.2% in 2024 and averaged 0.97%.
  • Per our database at Business Quant, DocGo's EBITDA Margin skyrocketed by 225100bps in 2021 and then tumbled by -68100bps in 2023.
  • Annual analysis of 5 years shows DocGo's EBITDA Margin stood at 15.05% in 2020, then surged by 150bps to 7.45% in 2021, then increased by 8bps to 8.03% in 2022, then plummeted by -85bps to 1.22% in 2023, then surged by 163bps to 3.2% in 2024.
  • Its EBITDA Margin stands at 3.2% for FY2024, versus 1.22% for FY2023 and 8.03% for FY2022.